These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 31733898)
1. Characterisation of utrophin modulator SMT C1100 as a non-competitive inhibitor of firefly luciferase. Wilkinson IVL; Reynolds JK; Galan SRG; Vuorinen A; Sills AJ; Pires E; Wynne GM; Wilson FX; Russell AJ Bioorg Chem; 2020 Jan; 94():103395. PubMed ID: 31733898 [TBL] [Abstract][Full Text] [Related]
2. Firefly luciferase in chemical biology: a compendium of inhibitors, mechanistic evaluation of chemotypes, and suggested use as a reporter. Thorne N; Shen M; Lea WA; Simeonov A; Lovell S; Auld DS; Inglese J Chem Biol; 2012 Aug; 19(8):1060-72. PubMed ID: 22921073 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of PTC124 activity in cell-based luciferase assays of nonsense codon suppression. Auld DS; Thorne N; Maguire WF; Inglese J Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3585-90. PubMed ID: 19208811 [TBL] [Abstract][Full Text] [Related]
4. Kinetics of inhibition of firefly luciferase by oxyluciferin and dehydroluciferyl-adenylate. Ribeiro C; Esteves da Silva JC Photochem Photobiol Sci; 2008 Sep; 7(9):1085-90. PubMed ID: 18754056 [TBL] [Abstract][Full Text] [Related]
5. Inhibiting Firefly Bioluminescence by Chalcones. Zhang H; Su J; Lin Y; Bai H; Liu J; Chen H; Du L; Gu L; Li M Anal Chem; 2017 Jun; 89(11):6099-6105. PubMed ID: 28492074 [TBL] [Abstract][Full Text] [Related]
6. Illuminating insights into firefly luciferase and other bioluminescent reporters used in chemical biology. Thorne N; Inglese J; Auld DS Chem Biol; 2010 Jun; 17(6):646-57. PubMed ID: 20609414 [TBL] [Abstract][Full Text] [Related]
7. Identification and synthesis of substituted pyrrolo[2,3-d]pyrimidines as novel firefly luciferase inhibitors. Liu Y; Fang J; Cai H; Xiao F; Ding K; Hu Y Bioorg Med Chem; 2012 Sep; 20(18):5473-82. PubMed ID: 22898255 [TBL] [Abstract][Full Text] [Related]
8. Safety, Tolerability, and Pharmacokinetics of SMT C1100, a 2-Arylbenzoxazole Utrophin Modulator, following Single- and Multiple-Dose Administration to Pediatric Patients with Duchenne Muscular Dystrophy. Ricotti V; Spinty S; Roper H; Hughes I; Tejura B; Robinson N; Layton G; Davies K; Muntoni F; Tinsley J PLoS One; 2016; 11(4):e0152840. PubMed ID: 27055247 [TBL] [Abstract][Full Text] [Related]
9. Firefly luciferase inhibitor-conjugated peptide quenches bioluminescence: a versatile tool for real time monitoring cellular uptake of biomolecules. Poutiainen PK; Rönkkö T; Hinkkanen AE; Palvimo JJ; Närvänen A; Turhanen P; Laatikainen R; Weisell J; Pulkkinen JT Bioconjug Chem; 2014 Jan; 25(1):4-10. PubMed ID: 24341748 [TBL] [Abstract][Full Text] [Related]
10. False positives in a reporter gene assay: identification and synthesis of substituted N-pyridin-2-ylbenzamides as competitive inhibitors of firefly luciferase. Heitman LH; van Veldhoven JP; Zweemer AM; Ye K; Brussee J; IJzerman AP J Med Chem; 2008 Aug; 51(15):4724-9. PubMed ID: 18646744 [TBL] [Abstract][Full Text] [Related]
11. Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124. Auld DS; Lovell S; Thorne N; Lea WA; Maloney DJ; Shen M; Rai G; Battaile KP; Thomas CJ; Simeonov A; Hanzlik RP; Inglese J Proc Natl Acad Sci U S A; 2010 Mar; 107(11):4878-83. PubMed ID: 20194791 [TBL] [Abstract][Full Text] [Related]
12. Safety, tolerability, and pharmacokinetics of SMT C1100, a 2-arylbenzoxazole utrophin modulator, following single- and multiple-dose administration to healthy male adult volunteers. Tinsley J; Robinson N; Davies KE J Clin Pharmacol; 2015 Jun; 55(6):698-707. PubMed ID: 25651188 [TBL] [Abstract][Full Text] [Related]
14. A basis for reduced chemical library inhibition of firefly luciferase obtained from directed evolution. Auld DS; Zhang YQ; Southall NT; Rai G; Landsman M; MacLure J; Langevin D; Thomas CJ; Austin CP; Inglese J J Med Chem; 2009 Mar; 52(5):1450-8. PubMed ID: 19215089 [TBL] [Abstract][Full Text] [Related]
15. Discovery of 5-benzyl-3-phenyl-4,5-dihydroisoxazoles and 5-benzyl-3-phenyl-1,4,2-dioxazoles as potent firefly luciferase inhibitors. Poutiainen PK; Palvimo JJ; Hinkkanen AE; Valkonen A; Väisänen TK; Laatikainen R; Pulkkinen JT J Med Chem; 2013 Feb; 56(3):1064-73. PubMed ID: 23286196 [TBL] [Abstract][Full Text] [Related]
16. Pyrrolo[2,3-b]quinoxalines as inhibitors of firefly luciferase: their Cu-mediated synthesis and evaluation as false positives in a reporter gene assay. Nakhi A; Rahman MS; Kishore R; Meda CL; Deora GS; Parsa KV; Pal M Bioorg Med Chem Lett; 2012 Oct; 22(20):6433-41. PubMed ID: 22981335 [TBL] [Abstract][Full Text] [Related]
18. Temperature-dependent intracellular crystallization of firefly luciferase in mammalian cells is suppressed by D-luciferin and stabilizing inhibitors. Hasegawa H Exp Cell Res; 2024 Jul; 440(1):114131. PubMed ID: 38876374 [TBL] [Abstract][Full Text] [Related]
19. Discovery and mechanism of action studies of 4,6-diphenylpyrimidine-2-carbohydrazides as utrophin modulators for the treatment of Duchenne muscular dystrophy. Vuorinen A; Wilkinson IVL; Chatzopoulou M; Edwards B; Squire SE; Fairclough RJ; Bazan NA; Milner JA; Conole D; Donald JR; Shah N; Willis NJ; Martínez RF; Wilson FX; Wynne GM; Davies SG; Davies KE; Russell AJ Eur J Med Chem; 2021 Aug; 220():113431. PubMed ID: 33915371 [TBL] [Abstract][Full Text] [Related]
20. Chemical Proteomics and Phenotypic Profiling Identifies the Aryl Hydrocarbon Receptor as a Molecular Target of the Utrophin Modulator Ezutromid. Wilkinson IVL; Perkins KJ; Dugdale H; Moir L; Vuorinen A; Chatzopoulou M; Squire SE; Monecke S; Lomow A; Geese M; Charles PD; Burch P; Tinsley JM; Wynne GM; Davies SG; Wilson FX; Rastinejad F; Mohammed S; Davies KE; Russell AJ Angew Chem Int Ed Engl; 2020 Feb; 59(6):2420-2428. PubMed ID: 31755636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]